Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
MRA has become the largest non-profit funder of melanoma research worldwide, helping to usher in a new paradigm in melanoma treatment.
A study in mice suggests that therapies approved for breast cancer may also combat other types, including colorectal and stomach cancer.
August is Summer Sun Safety Month.
“Our goal is to have perfect prediction to match patients to appropriate therapy,” said researcher Janis Taube, MD.
“You really have to be the CEO of your own health,” said melanoma survivor and patient advocate T. J. Sharpe.
SPORE grants have become the cornerstone of NCI’s efforts to advance collaborative, interdisciplinary translational cancer research.
Ken has lived with and in the shadow of melanoma since 1995, but he isn’t your typical patient and he hasn’t been cured of melanoma.
Can new therapies benefit patients with early stage melanoma, where spread of disease has yet to be observed?
Between 1970 and 2009, melanoma rates increased nearly 10-fold among women under 40.
“There were so many things that were outside of my control, so I decided to focus on the things that I could do something about.”
NKTR-214 plus Opdivo has been granted an FDA breakthrough therapy designation for advanced melanoma.
Some of the most common and deadly cancers receive little attention and resources.
An interview with Michael Kaplan, president and CEO of the Melanoma Research Alliance, about curing the deadliest skin cancer
The Cytophone device was able to detect a single cancer cell in a liter of blood.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.